Mucopolysaccharidosis (MPS) is often misdiagnosed, resulting in treatment delays that profoundly impact a patient’s future. The MPS Learning Zone equips frontline pediatricians and GPs with practical tools to detect early signs, initiate appropriate referrals, and ensure timely intervention. Access expert-led webinars, essential resources, and clinical insights — all in one place, designed to help you Think Rare in every consultation.
Our faculty brings together pediatric specialists, rare disease researchers, and clinicians at the forefront of MPS education. Their combined expertise fuels our mission to promote earlier diagnosis and improve care.
The MPS Resource Centre is independently developed and managed by EiP regarding content, topics and speakers appointed. Unrestricted grants are sought to support EIP activities, and Sanofi has provided an unrestricted grant to partially support EIP's work on the misdiagnosis of metabolic disorders.